Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro package contains a single KwikPen pre-loaded with four weekly doses of tirzepatide at your prescribed strength, along with the Patient Information Leaflet and the needles needed to administer each injection. That's the physical contents. But getting the package to your door legally requires a valid prescription following a clinical assessment — Mounjaro is a prescription-only medicine, and a prescriber must confirm it's appropriate for you before any pen is dispensed. If you've been searching for details on what to expect when your treatment arrives, or what the whole process looks like from consultation to delivery, this page walks through it step by step.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before a Mounjaro package can be dispensed, a prescriber must review your medical history, current medicines and weight to confirm the treatment is clinically appropriate. This isn't a formality. It's the step that separates a safe, effective course of treatment from a pen ordered from an unregulated seller, and it's what UK law requires for any prescription-only medicine.
At nume, a GPhC-registered Independent Prescriber reads every consultation personally, the same day. If you submit before noon on a weekday and are clinically approved, your package is dispatched that afternoon. A real clinician reviews it, not software, not an algorithm.
The full Mounjaro overview covers licensed eligibility in detail, but briefly: adults with a BMI of 30 or above qualify under the licence, as do those with a BMI from 27 with at least one weight-related condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A number alone never guarantees approval; the prescriber assesses the whole picture. NICE's appraisal of tirzepatide (TA1026) sets out the eligibility criteria in clinical detail if you want to read the source.
Opening the box for the first time is a moment many patients tell us felt more manageable than they'd expected. The package itself is straightforward.
Inside you'll find the KwikPen, a pre-filled, dial-up device that administers one dose each time you use it. Each pen contains four doses, covering a full four weeks of once-weekly treatment. The pen is supplied alongside injection needles (attach a fresh needle before each use), and the Patient Information Leaflet that the MHRA requires to accompany every dispensed medicine. The Mounjaro package insert is worth reading carefully before your first injection, it covers how to prime the pen, which body areas to inject into (abdomen, thigh or upper arm, rotating the site each week), and the exact storage window for room-temperature use if the pen is away from the fridge.
For a closer look at the physical presentation (labelling, pen design and packaging format) the Mounjaro packaging guide covers what a genuine UK-supply pen looks like, which is useful if you want to check that what you're receiving matches the authorised product.
The pen is stored refrigerated. Once outside the fridge, the SmPC specifies a permitted window for room-temperature use, always defer to the leaflet for the precise figures rather than any third-party source.
If you're new to tirzepatide, your first prescription will be for the 2.5 mg strength. The 2.5 mg pen's job is to let your system adjust, reducing early side effects, most of which are gastrointestinal (nausea, loose stools, indigestion) and tend to ease within a couple of weeks. That adjustment period matters, which is why the Mounjaro starter pack at 2.5 mg exists as a distinct first step in the schedule rather than a therapeutic target.
From there, your prescriber typically increases the strength every four weeks: 2.5 mg, then 5 mg, 7.5 mg, and so on up to the maximum 15 mg. Each repeat order is a different package, a new pen at the next strength, and you can find a full breakdown of what each supply includes on the Mounjaro pack page. At nume, every repeat requires a fresh clinical review before dispatch, so your prescriber can confirm the dose increase is appropriate and check in on how treatment is going. There are no automatic re-sends.
For patients comparing options or thinking about cost across the titration journey, the UK Mounjaro price comparison sets out what to look for in a legitimate provider, including what a quoted price should cover. Worth reading before you commit to any service.
SURMOUNT-1, the pivotal trial published in the New England Journal of Medicine, found that participants on the highest dose (15 mg) achieved an average body-weight reduction of around 20–21% over 72 weeks alongside a reduced-calorie diet and increased physical activity. Those figures are from a clinical-trial setting; individual results vary, and your prescriber will talk through realistic expectations during the consultation.
A Mounjaro package is temperature-sensitive, so how it's delivered matters as much as what's inside. At nume, approved orders are dispatched the same day (for consultations completed before noon, Monday to Friday) and delivered free the next working day by DPD in plain, unbranded packaging. You'll receive a tracking notification so you know when to be in, or can redirect if needed.
On arrival, check the pen immediately: the liquid should be clear or slightly yellow, with no particles. Store it in the fridge. If the package looks tampered with, the pen is damaged or the labelling doesn't match what you'd expect from a UK-authorised medicine, contact the pharmacy before using it. The NHS tirzepatide medicine page outlines what to look for and what to do if something seems wrong.
If you have questions about your specific package or dose, our support team is available seven days a week. For broader questions about how treatment works, the nume FAQs cover the topics patients ask most often. And when you're ready to check your eligibility and start the consultation, check your eligibility here, it's free, with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.